113 related articles for article (PubMed ID: 2549879)
1. [Recent trends of chemotherapy in small cell lung cancer: a slow but steady progress].
Ohnoshi T
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2522-30. PubMed ID: 2549879
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
Ueoka H; Kiura K; Tabata M; Kamei H; Gemba K; Sakae K; Hiraki Y; Hiraki S; Segawa Y; Harada M
Cancer; 1998 Jul; 83(2):283-90. PubMed ID: 9669811
[TBL] [Abstract][Full Text] [Related]
3. [Small cell lung cancer: a retrospective analysis of results of chemotherapy and combined modality treatment].
Ohnoshi T; Hiraki S; Ueoka H; Kawahara S; Numata T; Nishii K; Yonei T; Yamashta H; Kiura K; Kozuka A
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1341-8. PubMed ID: 2543304
[TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy of small cell lung cancer].
Fukuoka M; Negoro S; Takada M; Kusunoki Y; Matsui K; Ryu S; Sakai N; Yamamoto H; Masuda N; Takifuji N
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):966-72. PubMed ID: 2839116
[TBL] [Abstract][Full Text] [Related]
5. Alternating combination chemotherapy regimens in small-cell lung cancer.
Natale RB; Wittes RE
Semin Oncol; 1985 Mar; 12(1 Suppl 2):7-13. PubMed ID: 2983436
[TBL] [Abstract][Full Text] [Related]
6. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
[TBL] [Abstract][Full Text] [Related]
7. [Pilot phase II study of hybrid chemotherapy of CAV-PVP in small cell lung cancer (SCLC)].
Ueoka H; Ohnoshi T; Hiraki S; Kawahara S; Numata T; Nishii K; Yonei T; Yamashita H; Moritaka T; Kiura K
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2251-5. PubMed ID: 2544149
[TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy of small cell lung cancer].
Komiya T; Takada M
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1116-23. PubMed ID: 8751797
[TBL] [Abstract][Full Text] [Related]
9. Combined alkylators and multiple-site irradiation for extensive small cell lung cancer: a Southwest Oncology Group Study.
Livingston RB; Schulman S; Mira JG; Harker G; Vogel S; Coltman CA; Rivkin SE; Budd GT; Grever MR; Crowley JP
Cancer Treat Rep; 1986 Dec; 70(12):1395-401. PubMed ID: 3024826
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of lung cancer--state of the art in 2000].
Nakanishi Y; Inoue K; Hara N
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1247-52. PubMed ID: 10945023
[TBL] [Abstract][Full Text] [Related]
11. [Progress and obstacles in chemotherapy and combined modality treatment of small cell lung cancer].
Ohnoshi T; Ueoka H; Numata T; Kawahara S; Nishii K; Yonei T; Mima Y; Horiguchi T; Kiura K; Moritaka T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Feb; 28(2):190-6. PubMed ID: 2162437
[TBL] [Abstract][Full Text] [Related]
12. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic strategy for small cell lung cancer].
Fukuoka M
Nihon Geka Gakkai Zasshi; 1997 Jan; 98(1):46-52. PubMed ID: 9046518
[TBL] [Abstract][Full Text] [Related]
14. Dose-intensive weekly alternating chemotherapy for patients with small cell lung cancer: randomized trial, can it improve survival of patients with good prognostic factors?
Masutani M; Ochi Y; Kadota A; Akusawa H; Kisohara A; Takahashi N; Koya Y; Horie T
Oncol Rep; 2000; 7(2):305-10. PubMed ID: 10671676
[TBL] [Abstract][Full Text] [Related]
15. [Evidence based chemotherapy for lung cancer].
Watanabe H; Saijo N
Gan To Kagaku Ryoho; 2000 Jan; 27(1):30-43. PubMed ID: 10660731
[TBL] [Abstract][Full Text] [Related]
16. Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer.
Shepherd FA; Evans WK; MacCormick R; Feld R; Yau JC
Cancer Treat Rep; 1987 Oct; 71(10):941-4. PubMed ID: 2820571
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy for small cell lung cancer].
Fukuoka M; Takada M; Masuda N; Furuse K; Saijo N; Ikegami H; Nishiwaki Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():225-31. PubMed ID: 7516450
[TBL] [Abstract][Full Text] [Related]
18. [Small cell lung carcinoma: role of thoracic irradiation and its timing in relation to chemotherapy].
Payne DG; Murray N; Warde P
Bull Cancer; 1994 Feb; 81(2):119-28. PubMed ID: 7894117
[TBL] [Abstract][Full Text] [Related]
19. Etoposide plus ifosfamide plus cisplatin in the treatment of small cell lung cancer.
Sandler AB
Semin Oncol; 1998 Feb; 25(1 Suppl 2):38-41. PubMed ID: 9535210
[TBL] [Abstract][Full Text] [Related]
20. [Response rate of small cell lung cancer treated with CE-CAP alternating chemotherapy].
Zhang XR; Sun Y; Liu YY
Zhonghua Zhong Liu Za Zhi; 1994 Jul; 16(4):302-5. PubMed ID: 7805563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]